2m 2m 2m 2m 2m 2m 2m
Exelixis (EXEL)
NASDAQ
$58.40+$0.46 (+0.79%)
Price as of Oct 02, 2026 4:42 PM EDT- $14.4BMarket Cap
- 40.12%1-Year Change
- BiotechnologyIndustry
Exelixis (EXEL)
$58.40+$0.46 (+0.79%)
EXEL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $57.94 | ||
Change | -$0.47 (-0.80%) | ||
Open | $58.54 | ||
High | $59.28 | ||
Low | $57.76 | ||
Previous Close | $58.41 | ||
Volume | 1,369,460 | ||
30-Day Average Volume | 2,176,801 | ||
1-Week Change | -0.02% | ||
1-Month Change | 1.85% | ||
1-Year Change | 40.12% | ||
3-Year Change | 165.17% | ||
5-Year Change | 168.99% | ||
Fundamentals | |||
Shares Outstanding | 247.8M | ||
Total Assets | $2.5B | ||
Market Cap | $14.4B | ||
Enterprise Value | $14.1B | ||
Period: QTR TTM FY | |||
Revenue | $573.0M | ||
Net Income | $212.1M | ||
Free Cash Flow | $300.9M | ||
EBIT | $262.7M | ||
EBITDA | $269.7M | ||
Net Working Capital | $888.9M | ||
EPS | $0.82 | ||
Enterprise Value/EBITDA | 52 | ||
Enterprise Value/Revenue | 25 | ||
P/B | 8 | ||
P/E | 71 | ||
PEG | 19 | ||
Price/Free Cash Flow | 48 | ||
Price/Operating Cash Flow | 47 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue